Kevin X. Ali

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potential.

Development of a high-throughput screening platform for identification of functional BACH1 inhibitors reveals compounds with anti-invasive potential.

Journal: Redox biology
Published: March 10, 2026

Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening.

Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening.

Journal: Discover oncology
Published: June 11, 2025

Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors.

Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitors.

Journal: Redox biology
Published: March 10, 2025

Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis.

Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis.

Journal: Frontiers in oncology
Published: January 31, 2025

Ageing promotes metastasis via activation of the integrated stress response.

Ageing promotes metastasis via activation of the integrated stress response.

Journal: Nature
Published: June 20, 2024

STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles.

STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles.

Journal: Cell reports
Published: March 28, 2024

Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1.

Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1.

Journal: Free radical biology & medicine
Published: June 14, 2022

The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.

The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.

Journal: Redox biology
Published: February 15, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026